Typical guidance
No universal men's dose or protocol. Diagnosis, baseline risk, fertility goals, body size and monitoring determine treatment.

MODERN BIO / SLEEP / MEDICATION OR CLINICAL THERAPY
Clinical evidenceThis page is a practical starting point—not a diagnosis or personalized prescription. The useful dose depends on the outcome, the person and the quality of the intervention.
HOW TO USE THIS PAGE
Connect the intervention to a specific sleep outcome and review the evidence boundary.
Define amount, timing, quality standard and a realistic trial length before starting.
Choose the measure that will tell you to continue, adjust or stop.
RECOMMENDED RANGES
No universal men's dose or protocol. Diagnosis, baseline risk, fertility goals, body size and monitoring determine treatment.
No universal women's dose or protocol. Pregnancy potential, cycle or menopause status, clotting risk and monitoring may change treatment.
Important context: Prescription and procedural ranges must come from the treating clinician; sex is only one of several variables.
WHAT IT MAY HELP WITH
First-line treatment for chronic insomnia. Its relevance here is specifically connected to sleep. Outcomes can differ when the same intervention is used for another purpose.
This is an established clinical pathway for selected patients, but eligibility, dosing and monitoring are individualized.
SERVING & PROTOCOL
Eligibility, formulation and monitoring determine benefit and risk.
QUALITY CHECK
SAFETY & INTERACTIONS
Do not start, stop or change prescription treatment from general web guidance.
SCIENTIFIC EVIDENCE
Found clinically meaningful improvements in multiple sleep outcomes from CBT-I in adults with chronic insomnia.
Open scientific source ↗Provides the evidence base supporting behavioral and psychological treatments as core chronic-insomnia care.
Open scientific source ↗See the current indexed biomedical literature, including newer trials and reviews added after this page was published.
Open live PubMed search ↗Research quality is not determined by citation count alone. We consider design, sample size, controls, consistency, relevance, conflicts and whether the outcome was clinically meaningful.
MODERN BIO SELECT
The recommended option will be selected from licensed providers using evidence-aligned protocols, appropriate screening and ongoing monitoring.
Get notified when selected →We are vetting leading facilities for cbt-i based on clinician credentials, safety systems, transparency, outcomes and patient experience.
Join the provider shortlist →NEXT STEP